BlossomHill Therapeutics Releases Q2 2026 Financial Results Markets September 18, 2026 AlphaStreet Newsdesk powered by AlphaStreet Intelligence BLSM|EPS -$8.75|Web Loss $23.8M BlossomHill Therapeutics, Inc. (BLSM) reported a wider quarterly loss because…
